Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
18 September 2015Website:
http://www.penumbrainc.comNext earnings report:
01 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 65 min agoDividend
Analysts recommendations
Institutional Ownership
Included in screeners
PEN Latest News
ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024 at 4:30 PM Eastern Time.
A researcher initiated coverage of the medical device maker with a confident buy recommendation. He sees multiple positive factors that should propel its growth.
Penumbra receives the CE Mark approval for Lightning Flash 2.0 and Lightning Bolt 7 in Europe.
Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightning Flash™ 2.0 will be the most advanced thrombectomy system on the European market to address venous and pulmonary thrombus Lightning Bolt™ 7 is designed to enhance the ability to rapidly remove blood clots in the arteries with modulated aspiration, addressing conditions such as acute limb ischemia (ALI), hibernating thrombus and visceral occlusions ALAMEDA, Calif. , Sept. 16, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has secured CE Mark in Europe for the latest computer assisted vacuum thrombectomy (CAVT) technologies – Lightning Flash™ 2.0 and Lightning Bolt™ 7.
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
ALAMEDA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 10, 2024.
ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.
To Include $100 Million Accelerated Share Repurchase ALAMEDA, Calif. , Aug. 13, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a share repurchase authorization in the amount of up to $200 million, allowing Penumbra to repurchase its common stock from time to time at such prices as it deems appropriate through open market purchases, block transactions, privately negotiated transactions, including accelerated share repurchase transactions, or otherwise.
ALAMEDA, Calif. , Aug. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024.
While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
What type of business is Penumbra?
Penumbra, Inc. is a medical company focused on innovative treatment methods, which designs, develops, manufactures, and sells medical devices. The company's products are aimed at two main segments: vascular diseases and neurosurgery. In both of these markets, the company offers key products: thrombectomy systems - for removing blood clots (thrombi) and embolization systems - for treating patients with various sizes of aneurysms and other vascular and nervous disorders. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
What sector is Penumbra in?
Penumbra is in the Healthcare sector
What industry is Penumbra in?
Penumbra is in the Medical Devices industry
What country is Penumbra from?
Penumbra is headquartered in United States
When did Penumbra go public?
Penumbra initial public offering (IPO) was on 18 September 2015
What is Penumbra website?
https://www.penumbrainc.com
Is Penumbra in the S&P 500?
No, Penumbra is not included in the S&P 500 index
Is Penumbra in the NASDAQ 100?
No, Penumbra is not included in the NASDAQ 100 index
Is Penumbra in the Dow Jones?
No, Penumbra is not included in the Dow Jones index
When was Penumbra the previous earnings report?
No data
When does Penumbra earnings report?
The next expected earnings date for Penumbra is 01 November 2024